Efficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. Sandborn
3/16/2021
0:00
15:37
In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-integrin and S1P-1 receptor modulators, that are in late-stage development for treating moderate to severe CD.
More episodes from "MedEdTalks - Gastroenterology"
Don't miss an episode of “MedEdTalks - Gastroenterology” and subscribe to it in the GetPodcast app.